Share This Page
Drug Price Trends for GNP ALLERGY MULTI-SYMPTOM CPLT
✉ Email this page to a colleague

Average Pharmacy Cost for GNP ALLERGY MULTI-SYMPTOM CPLT
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
GNP ALLERGY MULTI-SYMPTOM CPLT | 46122-0660-62 | 0.08690 | EACH | 2025-06-18 |
GNP ALLERGY MULTI-SYMPTOM CPLT | 46122-0660-62 | 0.08744 | EACH | 2025-05-21 |
GNP ALLERGY MULTI-SYMPTOM CPLT | 46122-0660-62 | 0.08567 | EACH | 2025-04-23 |
GNP ALLERGY MULTI-SYMPTOM CPLT | 46122-0660-62 | 0.08331 | EACH | 2025-03-19 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
GNP Allergy Multi-Symptom Relief: Market Analysis and Price Projections
Overview of GNP Allergy Multi-Symptom Relief
GNP Allergy Multi-Symptom Relief is a medication designed to treat various symptoms associated with allergies, coughs, and colds. It typically contains a combination of active ingredients such as phenylephrine, acetaminophen, and sometimes antihistamines or expectorants like guaifenesin.
Market Context
Allergy Treatment Market Growth
The allergy treatment market is experiencing significant growth, driven by increasing allergy prevalence, advancements in treatment options, and growing awareness among individuals about available treatments. The market is projected to reach USD 42.7 billion by 2034, growing at a CAGR of 7.2% from 2024 to 2034[3].
Demand for Multi-Symptom Relief Medications
The demand for multi-symptom relief medications is on the rise due to the convenience they offer in managing multiple symptoms simultaneously. These medications are particularly popular during peak allergy and cold seasons, contributing to their steady market demand.
Key Ingredients and Their Roles
Phenylephrine
Phenylephrine is a sympathomimetic amine that acts as a post-synaptic alpha-adrenergic agonist, causing vasoconstriction and reducing nasal congestion. It is a common ingredient in many over-the-counter (OTC) cold and allergy medications[5].
Acetaminophen
Acetaminophen is used to relieve pain and reduce fever. It is often combined with other ingredients in multi-symptom relief medications to provide comprehensive symptom management[5].
Antihistamines and Expectorants
Antihistamines help alleviate allergy symptoms such as itching, sneezing, and runny nose, while expectorants like guaifenesin loosen and thin mucus, making it easier to cough up[5].
Safety and Regulatory Considerations
Age Restrictions
The FDA and manufacturers have implemented strict age restrictions for the use of cough and cold medications in children. For instance, these products should not be used in children under 4 years of age due to the risk of serious and potentially life-threatening adverse reactions[1][5].
Labeling and Packaging
Manufacturers have voluntarily modified labels and introduced child-resistant packaging to reduce the risk of unintentional ingestions and therapeutic errors. This has led to a significant decrease in ED visits related to cough and cold medication adverse events in young children[1][5].
Market Analysis
Competitive Landscape
The allergy treatment market is highly competitive, with numerous brands offering multi-symptom relief medications. GNP Allergy Multi-Symptom Relief competes with other OTC products that contain similar active ingredients. The market is driven by consumer preference for effective and safe treatments, as well as the availability of new and innovative products[3][4].
Regional Market Performance
North America, particularly the United States, is a significant market for allergy treatments due to advanced healthcare systems and high allergy prevalence. Europe and the Asia-Pacific region also show substantial growth, driven by increasing awareness and investments in healthcare[3][4].
Price Projections
Current Pricing
As of the current market, GNP Allergy Multi-Symptom Relief is priced around $12.19 per unit, which is competitive with other similar products in the market[2].
Future Pricing Trends
Given the growing demand for allergy treatments and the expected market expansion, prices for multi-symptom relief medications are likely to remain stable or see a moderate increase. However, competition and regulatory pressures could influence pricing strategies. Here are some potential trends:
- Stable Pricing: With the market expected to grow at a CAGR of 7.2%, manufacturers may maintain current prices to ensure affordability and market share.
- Moderate Increase: As demand increases and new technologies or formulations are introduced, prices might see a moderate rise to reflect the added value and innovation.
- Discounts and Promotions: To stay competitive, manufacturers might offer discounts, promotions, or loyalty programs to retain customers and attract new ones.
Key Takeaways
- Market Growth: The allergy treatment market is growing significantly, driven by increasing prevalence and advancements in treatments.
- Safety Considerations: Strict age restrictions and safety measures are in place to reduce adverse reactions in children.
- Competitive Landscape: The market is highly competitive, with multiple brands offering similar products.
- Pricing Trends: Prices are likely to remain stable or see a moderate increase due to market growth and competition.
FAQs
What are the main ingredients in GNP Allergy Multi-Symptom Relief?
The main ingredients typically include phenylephrine, acetaminophen, and sometimes antihistamines or expectorants like guaifenesin.
Why are there age restrictions for using GNP Allergy Multi-Symptom Relief in children?
Age restrictions are in place due to the risk of serious and potentially life-threatening adverse reactions in children under 4 years of age.
How is the allergy treatment market expected to grow in the next decade?
The allergy treatment market is expected to grow at a CAGR of 7.2% from 2024 to 2034, reaching USD 42.7 billion by 2034.
What are the key drivers of the allergy treatment market?
Key drivers include increasing allergy prevalence, advancements in treatment options, growing awareness, and the integration of precision medicine.
How does GNP Allergy Multi-Symptom Relief compare to other similar products in the market?
GNP Allergy Multi-Symptom Relief is competitively priced and contains similar active ingredients to other OTC multi-symptom relief medications.
What safety measures have been implemented for GNP Allergy Multi-Symptom Relief?
Manufacturers have implemented child-resistant packaging and modified labels to reduce the risk of unintentional ingestions and therapeutic errors.
Sources
- Cough and Cold Therapeutic Class Review (TCR) - Texas Health and Human Services[1]
- GNP Multi-symptom relief - Wellness Market Pharmacy[2]
- The Allergy Treatment Market is Set to Reach USD 42.7 Billion by 2034 - GlobeNewswire[3]
- Allergy Treatment Market Size and Share Projected to Surpass USD 34.9 Billion by 2034 - GlobeNewswire[4]
- Cough and Cold Therapeutic Class Review (TCR) - Texas Health and Human Services[5]
More… ↓